Philippe Barthélémy

14.8k citations
302 papers · 6.4k indexed · 1 hit paper · h-index 42

Impact in

Papers in

Philippe Barthélémy

288 papers receiving 6.3k citations

Hit Papers

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial 2020 · 347 citations
3472020202620222024100200300

Peers

Philippe Barthélémy
Comparison fields: 5 of 174
  • Gastroenterology 593
  • Biomaterials 1.2k
  • Molecular Medicine 222
  • Pulmonary and Respiratory Medicine 1.4k
  • Molecular Biology 2.8k
Replace Tadao Kakizoe with:
Tadao Kakizoe Japan
Rui Manuel Reis Brazil
Ross C. Donehower United States
Kees Nooter Netherlands
Xuelei Ma China
Sandrine Faivre France
Michael Hawkins United States
Franco M. Muggia United States
Giuseppe Toffoli Italy
Michael V. Seiden United States
Philippe Barthélémy relative to Tadao Kakizoe Japan Tadao Kakizoe's profile →
Citations per field
00.5×4.7×
Tadao Kakizoe · 1×
Citations per year

Countries citing papers authored by Philippe Barthélémy

Since Specialization
Citations

This map shows the geographic impact of Philippe Barthélémy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Barthélémy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Barthélémy more than expected).

Fields of papers citing papers by Philippe Barthélémy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Barthélémy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Barthélémy. The network helps show where Philippe Barthélémy may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Barthélémy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Barthélémy Line = papers co-authored together Philippe Barthélémy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20243
4 20242
5 20231
6 20231
7 20232
8 202313
9 20223
10 202210
11 20223
12 202111
13 20217
14 201813
15
Pertuzumab: development beyond breast cancer.
201431
16 20141
17
Duration of adjuvant trastuzumab treatment in routine practice.
201211
18 200536
19 1989128
20
[The first branchial arch syndrome].
19661

About Philippe Barthélémy

Philippe Barthélémy is a scholar working on Gastroenterology, Biomaterials, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 302 papers that have together received 6.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (56 papers), Renal cell carcinoma treatment (48 papers), Advanced biosensing and bioanalysis techniques (44 papers), Supramolecular Self-Assembly in Materials (37 papers), DNA and Nucleic Acid Chemistry (33 papers), Prostate Cancer Treatment and Research (23 papers), Helicobacter pylori-related gastroenterology studies (22 papers) and Cancer Immunotherapy and Biomarkers (21 papers). The work is most often cited by research in Gastroenterology (593 citations), Biomaterials (1.2k citations), Molecular Medicine (222 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Molecular Biology (2.8k citations). Philippe Barthélémy has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Mark W. Grinstaff, Arnaud Gissot, Michel Camplo, Guilhem Godeau, Louis Moreau, Cathy Staedel, Bernard Pucci, Laurent Latxague, Carla A. H. Prata and J. P. Galmiche. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Bioconjugate Chemistry, Chemical Communications and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026